United States v. Glaxo Group Ltd.
United States v. Glaxo Group Ltd.
United States v. Glaxo Group Ltd. was a significant United States Supreme Court case decided in 1973. The case addressed issues related to patent law and antitrust law in the context of the pharmaceutical industry.
Background
The case arose from a dispute involving the Glaxo Group Ltd., a major pharmaceutical company, and the United States government. The government alleged that Glaxo had engaged in anticompetitive practices by using its patents to unlawfully extend its monopoly over certain pharmaceutical products.
Legal Issues
The primary legal issue in the case was whether Glaxo's use of its patents violated antitrust laws, specifically the Sherman Antitrust Act. The government argued that Glaxo's licensing agreements and patent practices restricted competition and maintained artificially high prices for its drugs.
Supreme Court Decision
The Supreme Court ruled in favor of the United States, holding that Glaxo's patent practices constituted an unlawful restraint of trade. The Court's decision emphasized the importance of balancing patent rights with the need to maintain competitive markets.
Impact
The decision in United States v. Glaxo Group Ltd. had a significant impact on the pharmaceutical industry and patent law. It reinforced the principle that patent rights cannot be used to justify anticompetitive behavior and highlighted the role of antitrust laws in regulating the use of patents.
Related pages
References
- "United States v. Glaxo Group Ltd.," 410 U.S. 52 (1973).
- "Antitrust and Patent Law: The Supreme Court's Decision in United States v. Glaxo Group Ltd.," Journal of Law and Economics.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
